Crescent Capital BDC (NASDAQ:CCAP) Stock Price Expected to Rise, Keefe, Bruyette & Woods Analyst Says

Crescent Capital BDC (NASDAQ:CCAP) had its price target lifted by stock analysts at Keefe, Bruyette & Woods from $19.00 to $20.00 in a research report issued on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Keefe, Bruyette & Woods’ price objective would suggest a potential upside of 3.79% from the stock’s current price.

A number of other analysts have also recently weighed in on the company. Bank of America decreased their price objective on Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating for the company in a research report on Thursday, August 15th. LADENBURG THALM/SH SH started coverage on Crescent Capital BDC in a report on Monday, September 30th. They set a “buy” rating and a $20.00 price target for the company. Finally, Wells Fargo & Company lowered their price objective on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 14th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $19.17.

Crescent Capital BDC Price Performance

Shares of NASDAQ:CCAP opened at $19.27 on Monday. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.26 and a current ratio of 1.26. Crescent Capital BDC has a one year low of $15.91 and a one year high of $19.63. The company has a 50-day simple moving average of $18.56 and a 200-day simple moving average of $18.51. The stock has a market capitalization of $714.15 million, a price-to-earnings ratio of 7.56 and a beta of 0.81.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. HighTower Advisors LLC boosted its position in shares of Crescent Capital BDC by 0.5% during the 3rd quarter. HighTower Advisors LLC now owns 141,838 shares of the company’s stock worth $2,624,000 after purchasing an additional 768 shares in the last quarter. Confluence Investment Management LLC lifted its stake in shares of Crescent Capital BDC by 2.2% in the third quarter. Confluence Investment Management LLC now owns 73,206 shares of the company’s stock valued at $1,354,000 after purchasing an additional 1,583 shares during the period. Point72 Asset Management L.P. purchased a new stake in Crescent Capital BDC during the second quarter worth about $90,000. Sumitomo Mitsui Trust Holdings Inc. grew its position in Crescent Capital BDC by 14.1% during the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 80,766 shares of the company’s stock worth $1,517,000 after buying an additional 10,000 shares during the period. Finally, XTX Topco Ltd purchased a new position in Crescent Capital BDC in the second quarter valued at about $195,000. Hedge funds and other institutional investors own 49.46% of the company’s stock.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.